PTGS2 was found to be common between both conditions as a highly expressed gene and was among the top hub genes, suggesting that it can be used as a promising target in combating both conditions related to PTB, that is, PE and PE + IUGR. The gene discussed is PTGS2; the disease is fetal growth restriction.